New Data Highlights Etrasimod’s Potential for Atopic Dermatitis

Top Researcher of Itch and Inflammatory Skin Conditions to Join Mount Sinai’s Department of Dermatology

Mount Sinai Awarded Prestigious $4 Million Grant to Launch Skin Biology and Diseases Resource-based Center

After Lifetime Struggle with Eczema, Man Found Treatment that's 'Doing Wonders'

Study Finds Oral, Arthritis Drug RINVOQ Effective Against Moderate To Severe Eczema

Oral Medication Shows Strong Promise for Moderate to Severe Atopic Dermatitis in Mount Sinai-led Study

$10 Million Gift to Open the Kimberly and Eric J. Waldman Melanoma and Skin Cancer Center at Mount Sinai

Etrasimod Significantly Improves Atopic Dermatitis in Phase 2b Trial

Etrasimod Performs Well in Phase Phase 2b Trial of Adult Atopic Dermatitis

"Losing Your Hair Can Be Another Consequence of the Pandemic" - Pam Belluck

Mount Sinai Health System Names New Chair of Dermatology and Announces Dean for Clinical Therapeutics